These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17002635)

  • 1. Viability of red cells prepared with S-303 pathogen inactivation treatment.
    Rios JA; Hambleton J; Viele M; Rugg N; Sindermann G; Greenwalt T; Wages D; Cook D; Corash L
    Transfusion; 2006 Oct; 46(10):1778-86. PubMed ID: 17002635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process.
    Cancelas JA; Dumont LJ; Rugg N; Szczepiorkowski ZM; Herschel L; Siegel A; Pratt PG; Worsham DN; Erickson A; Propst M; North A; Sherman CD; Mufti NA; Reed WF; Corash L
    Transfusion; 2011 Nov; 51(11):2367-76. PubMed ID: 21569044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre study.
    Cancelas JA; Gottschall JL; Rugg N; Graminske S; Schott MA; North A; Huang N; Mufti N; Erickson A; Rico S; Corash L
    Vox Sang; 2017 Apr; 112(3):210-218. PubMed ID: 28220519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods.
    Luten M; Roerdinkholder-Stoelwinder B; Schaap NP; de Grip WJ; Bos HJ; Bosman GJ
    Transfusion; 2008 Jul; 48(7):1478-85. PubMed ID: 18482180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.
    Goodrich RP; Murthy KK; Doane SK; Fitzpatrick CN; Morrow LS; Arndt PA; Reddy HL; Buytaert-Hoefen KA; Garratty G
    Transfusion; 2009 Jan; 49(1):64-74. PubMed ID: 18954398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients.
    Benjamin RJ; McCullough J; Mintz PD; Snyder E; Spotnitz WD; Rizzo RJ; Wages D; Lin JS; Wood L; Corash L; Conlan MG
    Transfusion; 2005 Nov; 45(11):1739-49. PubMed ID: 16271099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infusion of P-Capt prion-filtered red blood cell products demonstrate acceptable in vivo viability and no evidence of neoantigen formation.
    Cancelas JA; Rugg N; Pratt PG; Worsham DN; Pehta JC; Banks K; Davenport RD; Judd WJ
    Transfusion; 2011 Oct; 51(10):2228-36. PubMed ID: 21492178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment.
    Winter KM; Johnson L; Kwok M; Vidovic D; Hyland RA; Mufti N; Erickson A; Marks DC
    Transfusion; 2014 Jul; 54(7):1798-807. PubMed ID: 24617658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransfusion recovery of stored red blood cells in very low birth weight infants using a hemoglobin balance model.
    Bechensteen AG; Chapel S; Veng-Pedersen P; Widness JA
    Transfusion; 2004 Jul; 44(7):1019-24. PubMed ID: 15225242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatment.
    North A; Ciaravino V; Mufti N; Corash L
    Transfusion; 2011 Oct; 51(10):2208-18. PubMed ID: 21985050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of an in vitro biotinylation technique for determination of posttransfusion survival of fresh and stored autologous red blood cells in Thoroughbreds.
    Owens SD; Johns JL; Walker NJ; Librach FA; Carrade DD; Tablin F; Borjesson DL
    Am J Vet Res; 2010 Aug; 71(8):960-6. PubMed ID: 20673097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of LEUKOSEP HRC-600-C leukoreduction filtration system for red cells.
    AuBuchon JP; Cancelas JA; Herschel L; Roger J; Rugg N; Pratt PG; Joines A; Gormas JF; Zia M; Spearman MR
    Transfusion; 2006 Aug; 46(8):1311-5. PubMed ID: 16934065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC.
    Mufti NA; Erickson AC; North AK; Hanson D; Sawyer L; Corash LM; Lin L
    Biologicals; 2010 Jan; 38(1):14-9. PubMed ID: 19995680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery.
    Brixner V; Kiessling AH; Madlener K; Müller MM; Leibacher J; Dombos S; Weber I; Pfeiffer HU; Geisen C; Schmidt M; Henschler R; North A; Huang N; Mufti N; Erickson A; Ernst C; Rico S; Benjamin RJ; Corash LM; Seifried E
    Transfusion; 2018 Apr; 58(4):905-916. PubMed ID: 29498049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of the fittest?--survival of stored red blood cells after transfusion.
    Luten M; Roerdinkholder-Stoelwinder B; Bost HJ; Bosman GJ
    Cell Mol Biol (Noisy-le-grand); 2004 Mar; 50(2):197-203. PubMed ID: 15095790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gamma irradiation on the in vivo recovery of stored red blood cells.
    Mintz PD; Anderson G
    Ann Clin Lab Sci; 1993; 23(3):216-20. PubMed ID: 8323256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The age of red blood cells in premature infants (ARIPI) randomized controlled trial: study design.
    Fergusson D; Hutton B; Hogan DL; LeBel L; Blajchman MA; Ford JC; Hebert P; Kakadekar A; Kovacs L; Lee S; Sankaran K; Shapiro S; Smyth JA; Ramesh K; Bouali NR; Tinmouth A; Walker R
    Transfus Med Rev; 2009 Jan; 23(1):55-61. PubMed ID: 19056034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stored erythrocytes have less capacity than normal erythrocytes to support primary haemostasis.
    Reinhart WH; Zehnder L; Schulzki T
    Thromb Haemost; 2009 Apr; 101(4):720-3. PubMed ID: 19350117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated collection of double red blood cell units with a variable-volume separation chamber.
    Aubuchon JP; Dumont LJ; Herschel L; Roger J; Beddard RL; Taylor HL; Whitley PH; Sawyer SL; Graminske S; Martinson K; Dora R; Heldke S; Adamson J; Rose LE
    Transfusion; 2008 Jan; 48(1):147-52. PubMed ID: 17894787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended storage of AS-1 and AS-3 leukoreduced red blood cells for 15 days after deglycerolization and resuspension in AS-3 using an automated closed system.
    Bandarenko N; Hay SN; Holmberg J; Whitley P; Taylor HL; Moroff G; Rose L; Kowalsky R; Brumit M; Rose M; Sawyer S; Johnson A; McNeil D; Popovsky MA
    Transfusion; 2004 Nov; 44(11):1656-62. PubMed ID: 15504173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.